Literature DB >> 23264364

Rapid progression to decompensated cirrhosis, liver transplant, and death in HIV-infected men after primary hepatitis C virus infection.

Daniel S Fierer1, Douglas T Dieterich, M Isabel Fiel, Andrea D Branch, Kristen M Marks, Dahlene N Fusco, Ricky Hsu, Davey M Smith, Joshua Fierer.   

Abstract

BACKGROUND: We and others have shown that primary hepatitis C (HCV) infection in men infected with human immunodeficiency virus (HIV) causes early-onset liver fibrosis; however, little is known about the long-term natural history of the liver disease in these HIV-infected men.
METHODS: We followed a cohort of HIV-infected men with primary HCV infection in New York City.
RESULTS: Four men who were not cured after their primary HCV infection developed decompensated cirrhosis within 17 months to 6 years after primary HCV infection. Three died within 8 years of primary HCV infection, and 1 survived after liver transplant done 2 years after primary HCV infection. Three of the 4 men had AIDS at the time of primary HCV infection, and the most rapid progression occurred in the 2 men with the lowest CD4 counts at the time of HCV infection. Liver histopathology was most consistent with HCV-induced damage even though some had exposures to other potential hepatotoxins.
CONCLUSIONS: Primary HCV infection resulted in decompensated cirrhosis and death within 2-8 years in 4 HIV-infected men. The rapid onset of fibrosis due to primary HCV infection in HIV-infected men cannot therefore be considered benign. The rate of continued progression to liver failure may be proportional to the degree of underlying immunocompromise caused by HIV infection. More research is needed to better define the mechanisms behind accelerated liver damage.

Entities:  

Mesh:

Year:  2012        PMID: 23264364      PMCID: PMC3588118          DOI: 10.1093/cid/cis1206

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  28 in total

1.  Hepatitis C virus infection in HIV-infected men who have sex with men: sustained rising incidence in Antwerp, Belgium, 2001-2009.

Authors:  E Bottieau; L Apers; M Van Esbroeck; M Vandenbruaene; E Florence
Journal:  Euro Surveill       Date:  2010-09-30

2.  Severe liver disease associated with prolonged exposure to antiretroviral drugs.

Authors:  Ivana Maida; Marina Núñez; Maria Jose Ríos; Luz Martín-Carbonero; Giovanni Sotgiu; Carlos Toro; Pablo Rivas; Pablo Barreiro; Maria Stella Mura; Sergio Babudieri; Javier Garcia-Samaniego; Juan González-Lahoz; Vincent Soriano
Journal:  J Acquir Immune Defic Syndr       Date:  2006-06       Impact factor: 3.731

3.  The development of hepatoportal sclerosis and portal hypertension due to didanosine use in HIV.

Authors:  Thomas D Schiano; Alison Uriel; Douglas T Dieterich; M Isabel Fiel
Journal:  Virchows Arch       Date:  2010-11-06       Impact factor: 4.064

4.  Factors associated with seronegative chronic hepatitis C virus infection in HIV infection.

Authors:  Gabriel Chamie; Maurizio Bonacini; David R Bangsberg; Jack T Stapleton; Christopher Hall; E Turner Overton; Rebecca Scherzer; Phyllis C Tien
Journal:  Clin Infect Dis       Date:  2007-01-10       Impact factor: 9.079

5.  The natural history of liver cirrhosis in HIV-hepatitis C virus-coinfected patients.

Authors:  María López-Diéguez; María L Montes; José F Pascual-Pareja; Carmen Quereda; Miguel A Von Wichmann; Juan Berenguer; Cristina Tural; Asunción Hernando; Juan González-García; Lucia Serrano; José R Arribas
Journal:  AIDS       Date:  2011-04-24       Impact factor: 4.177

6.  Sexual transmission of hepatitis C virus among HIV-infected men who have sex with men--New York City, 2005-2010.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-07-22       Impact factor: 17.586

Review 7.  The natural history of recurrent hepatitis C and what influences this.

Authors:  Edward J Gane
Journal:  Liver Transpl       Date:  2008-10       Impact factor: 5.799

Review 8.  Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis.

Authors:  Hla-Hla Thein; Qilong Yi; Gregory J Dore; Murray D Krahn
Journal:  AIDS       Date:  2008-10-01       Impact factor: 4.177

9.  Liver fibrosis during an outbreak of acute hepatitis C virus infection in HIV-infected men: a prospective cohort study.

Authors:  Daniel S Fierer; Alison J Uriel; Damaris C Carriero; Arielle Klepper; Douglas T Dieterich; Michael P Mullen; Swan N Thung; M Isabel Fiel; Andrea D Branch
Journal:  J Infect Dis       Date:  2008-09-01       Impact factor: 5.226

10.  Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men.

Authors:  Thijis van de Laar; Oliver Pybus; Sylvia Bruisten; David Brown; Mark Nelson; Sanjay Bhagani; Martin Vogel; Alex Baumgarten; Marie-Laure Chaix; Martin Fisher; Hannelore Gotz; Gail V Matthews; Stefan Neifer; Peter White; William Rawlinson; Stanislav Pol; Jurgen Rockstroh; Roel Coutinho; Greg J Dore; Geoffrey M Dusheiko; M Danta
Journal:  Gastroenterology       Date:  2009-05       Impact factor: 22.682

View more
  24 in total

1.  Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.

Authors: 
Journal:  Clin Infect Dis       Date:  2018-10-30       Impact factor: 9.079

Review 2.  Acute HCV in HIV-infected MSM: modes of acquisition, liver fibrosis, and treatment.

Authors:  Emma Kaplan-Lewis; Daniel Seth Fierer
Journal:  Curr HIV/AIDS Rep       Date:  2015-09       Impact factor: 5.071

3.  Fibrosis Progression in Patients With Chronic Hepatitis C Virus Infection.

Authors:  Marija Zeremski; Rositsa B Dimova; Jaroslaw Pillardy; Ype P de Jong; Ira M Jacobson; Andrew H Talal
Journal:  J Infect Dis       Date:  2016-08-02       Impact factor: 5.226

4.  Telaprevir in the treatment of acute hepatitis C virus infection in HIV-infected men.

Authors:  Daniel S Fierer; Douglas T Dieterich; Michael P Mullen; Andrea D Branch; Alison J Uriel; Damaris C Carriero; Wouter O van Seggelen; Rosanne M Hijdra; David G Cassagnol
Journal:  Clin Infect Dis       Date:  2013-12-13       Impact factor: 9.079

5.  Macrophage Activation and the Tumor Necrosis Factor Cascade in Hepatitis C Disease Progression Among HIV-Infected Women Participating in the Women's Interagency HIV Study.

Authors:  Audrey L French; Jonathan W Martin; Charlesnika T Evans; Marion Peters; Seble G Kessaye; Marek Nowicki; Mark Kuniholm; Elizabeth Golub; Michael Augenbraun; Seema N Desai
Journal:  J Acquir Immune Defic Syndr       Date:  2017-12-01       Impact factor: 3.731

Review 6.  HCV and HIV co-infection: mechanisms and management.

Authors:  Jennifer Y Chen; Eoin R Feeney; Raymond T Chung
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-02-18       Impact factor: 46.802

7.  Insights Into the Pathophysiology of Liver Disease in HCV/HIV: Does it End With HCV Cure?

Authors:  Andre J Jeyarajan; Raymond T Chung
Journal:  J Infect Dis       Date:  2020-11-27       Impact factor: 5.226

Review 8.  Treatment of genotype 1 HCV infection in the HIV coinfected patient in 2014.

Authors:  Cody A Chastain; Susanna Naggie
Journal:  Curr HIV/AIDS Rep       Date:  2013-12       Impact factor: 5.071

9.  Metabolic Syndrome in HIV/HCV Co-infected Patients.

Authors:  Lauren F Collins; Ruth O Adekunle; Emily J Cartwright
Journal:  Curr Treat Options Infect Dis       Date:  2019-12-02

10.  Effect of incident hepatitis C infection on CD4+ cell count and HIV RNA trajectories based on a multinational HIV seroconversion cohort.

Authors:  Daniela K van Santen; Jannie J van der Helm; Giota Touloumi; Nikos Pantazis; Roberto Muga; Barbara Gunsenheimer-Bartmeyer; M John Gill; Eduard Sanders; Anthony Kelleher; Robert Zangerle; Kholoud Porter; Maria Prins; Ronald B Geskus
Journal:  AIDS       Date:  2019-02-01       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.